Uncategorized

Sanofi is the only company to leverage its manufacturing capacity and expertise to support three different COVID-19 vaccines to support the global supply of vaccines and help address the pandemic Sanofi to manufacture up to 200 million doses of Moderna’s vaccine in the U.S. starting in September 2021 MEDIA UPDATE – April 26, 2021 Sanofi…

Original Post: https://www.massdevice.com/stryker-sells-t-pump-product-line-to-c2dx/ C2Dx today announced that it has acquired Stryker’s T/Pump product line for an undisclosed amount. The T/Pump product line provides localized temperature therapy for pain relief and patient comfort. It is used for orthopedic conditions, acute injuries, chronic pain, and muscle strains. It can also be used for skin trauma, burns, contusions,…

Story Originally Published by Pfizer here. COMIRNATY® (also known as BNT162b2) receives conditional marketing authorization from the European Commission; this milestone represents a global joint effort to advance the first authorized mRNA vaccine Pfizer and BioNTech are ready to immediately ship initial doses to the 27 EU member states Pfizer and BioNTech previously announced an agreement…

Story Originally Published by BIO here. Public opinion polls show there is significant mistrust among the American public in the safety and efficacy of vaccines. So today, the Biotechnology Innovation Organization (BIO) announced the launch of COVIDVaccineFacts.org. As a subsidiary website of BIO, COVIDVaccineFacts.org is an educational tool that links healthcare providers and the public…